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Background/Aims: The aim of this study was to investigate 
the primary management experience for giant liver heman-
giomas greater than 20 cm in size. Methods: Records of 
patients referred for evaluation of radiologically and/or histo-
pathologically proven giant liver hemangiomas between Jan-
uary 2007 and March 2010 were retrospectively analyzed. 
The reasons for referral, results of imaging studies, preopera-
tive and surgical treatments, and outcome were reviewed. 
Results: A retrospective analysis was performed for 14 
patients diagnosed with a giant hemangioma on the basis 
of an imaging study and/or a histopathological examination. 
All cases were diagnosed as giant liver hemangioma with at 
least one lesion greater than 20 cm in size. Abdominal dis-
comfort was the main presenting complaint for the referral 
in 9 patients (64.2%). Abdominal ultrasound established the 
diagnosis in 12 patients (85.7%). Twelve patients underwent 
liver resection, 2 of whom underwent staged resection. Enu-
cleation was performed in 2 patients. Selective transcath-
eter arterial embolization was implemented in 9 patients. 
Postoperative morbidity occurred in 3 patients (21.4%). No 
complications related to the hemangiomas occurred during 
follow up. Conclusions: Liver resection is indicated for giant 
liver hemangiomas with abdominal discomfort, especially 
for lesions greater than 20 cm in size. Staged operations are 
performed for patients with multiple lesions. Preoperative se-
lective transcatheter arterial embolization alleviates progres-
sive abdominal pain. (Gut Liver 2011;5:228-233)
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INTRODUCTION
Hemangiomas are the most common benign tumor of the 
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liver with an estimated prevalence of 0.4% to 20%.
1 The major-
ity of these patients are asymptomatic and seldom presented 
with specific clinical feature. Therefore, these lesions are usu-
ally detected incidentally through the increased use of imaging 
method for abdominal complaints. These tumors are soft and 
seldom cause compression of bile ducts, portal vein or inferior 
vena cava (IVC). Most hemangiomas are small and need no 
treatment or further follow-up as they have no hazardous effect 
and damage to adjacent organs. Only giant liver hemangiomas 
may give rise to mechanical complaints requiring surgical in-
tervention. And giant liver hemangioma was defined as the one 
with diameter greater than 5 cm.
2 In recent years, many reports 
regarding surgical treatment demonstrated good long-term 
outcome.
3 However, there remains a very difficult challenge in 
surgical procedure for hemangioma greater than 20 cm because 
intraoperative bleeding is higher and it may difficult to control. 
Discussion about the management of giant liver hemangiomas 
with diameter greater than 20 cm is scarce.
More than 1,000 patients accepted liver resection in our cen-
ter every year from January 2007, among which about 80 to 
100 cases were for giant hemangioma, and 3 to 8 cases with at 
least one lesion greater than 20 cm underwent surgical treat-
ment. Indications for surgery in our center are based on heman-
giomas greater than 10 cm, as well as hemangiomas less than 
10 cm with progressive abdominal pain, increase in size or with 
difficulty in excluding malignancy.
The aim of this study is to introduce our experiences of man-
agement of the patients with giant liver hemangioma greater 
than 20 cm.
MATERIALS AND METHODS
1. Patients
A search of the departmental database was carried out for the 
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patients who underwent treatment of giant liver hemangioma. 
The 3-year period from January 2007 to March 2010 inclusive 
was reviewed. Patients were included in the study if they met 
the criteria of having one lesion greater than 20 cm, or mul-
tiple lesions with at least one greater than 20 cm. Patients were 
excluded if they were not amenable to hepatectomy, as well as 
those who complicated primary liver cancer confirmed preop-
eratively.
The medical records were reviewed for documentation of pre-
senting symptoms or indications for further analysis, transcath-
eter arterial embolization, surgical procedure, blood transfusion 
and/or autologous transfusion, postoperative stay, and follow-
up, including postoperative complications. Results of imaging 
studies including ultrasound (US) and computed tomography 
(CT) were reviewed to record total number, size and location of 
the liver hemangiomas.
2. Preoperative treatment
In each patient, the indication for surgery was discussed and 
written informed consent taken. Indocyanine green clearance 
test was performed in all patients to determine the hepatic func-
tion reserve. The choice of surgical procedure was at the discre-
tion of the individual surgeon. The type of liver resection per-
formed was based on the size and location of the hemangioma. 
For patients with multiple giant hemangiomas, we tried to resect 
all the lesions at one time. However, considering the hepatic 
function of liver remnant, staged resection was implemented in 
selected patients.
Transcatheter arterial embolization was implemented in se-
lected patients for alleviating progressive abdominal discomfort 
if the operation was not performed within 3 to 5 days.
Before considering surgical resection, other possible causes 
of abdominal complaints such as gallstones, gastroesophageal 
reflux disease or pancreatitis were excluded. 
What’s more, the cell-saver apparatus was prepared for au-
tologous transfusion in all cases before surgical resection.
3. Surgical technique
A right shape incision was made below the bilateral costal 
margin and a variable upper abdominal self-retaining retractor 
was used to expose the operating field. Each hepatic ligament 
was liberated and cut off. The infra- and suprahepatic IVC was 
liberated and then taped to control blood flow, and the same 
was done for the hepatic pedicle. Hepatic artery and portal vein 
of lesion side was cut down in patients who need hemihepatec-
tomy to decrease bleeding.
Before separation, the plane of demarcation was delineated 
by intraoperative ultrasound. When it was considered that a 
large amount of blood would be lost and/or the operating area 
was near a vital vessel, the infra- and suprahepatic IVC were 
excluded in turn to block the total hepatic blood supply so that 
the vital vessels could be operated on safely and the blood leak-
age could be corrected. The opening of the vascular exclusion 
was in the reverse order. 
The resection together with absorption was done from the 
boundary between the hemangioma and the normal hepatic 
tissue with CUSA, which could decrease the bleeding at the 
incisional edge. Small diameter nutrient vessels were electro-
coagulated and titanium clips had been implemented to small 
vessels, while large ones were ligated. Only the tumor was re-
moved by this method with little hepatic tissue damaged. The 
resection along the boundary between the hemangioma and the 
normal hepatic tissue led to little blood loss.
Table 1. Characteristics of 14 Patients with Giant Liver Hemangiomas
Patient no. Age, yr Sex Clinical presentation Location and tumor size, cm Total no.
1 32 F Incidental finding Right lobe (21.7×9.5) 1
2 49 F Abdominal pain Right lobe (22.5×7.6) 1
3 55 M Elevated cholestatic parameters Left lobe (24.6×7.9) 1
4 42 F Abdominal distention Left lobe (26.2×6.9) 1
5 40 F Abdominal pain Right lobe (24.1×11.6) 1
6 29 F Incidental finding Right lobe (24.4×9.0) 1
7 52 F Abdominal pain Right lobe (22.6×11.3) 1
8 68 M Incidental finding Right lobe (20.4×7.9) 1
9 47 F Elevated cholestatic parameters Left lobe (20.1×6.8), segment VI (7.8×5.2) 2
10 44 F Abdominal pain Right lobe (21.9×14.3) 1
11 36 F Abdominal pain Right lobe (21.4×6.4) 1
12 49 F Abdominal distention Left lobe (20.2×7.3), caudate lobe (17.7×8.5), segment VI (7.8×5.7) 3
13 51 F Abdominal pain Right lobe (21.5×7.3) 1
14 37 F Abdominal distention Left lobe (28.4×8.6) 1
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4. Postoperative treatment
The postoperative treatment included the return to oral feed-
ing after 48 hours via nasogastric aspiration, inhibitors of 
gastric acid secretion and broad-spectrum antibiotics, daily bio-
chemical monitoring of blood tests, and of hepatic function for 
the first 5 postoperative days.
5. Follow-up
After discharge, the clinical conditions as well as the hepatic 
function of all patients were monitored with a median follow-
up of 16.3±1.6 months (range, 3 to 43 months). Morphological 
findings of liver were obtained by US and/or abdominal CT.
RESULTS
A total of 14 patients were treated with liver resection over 
the 3-year period of the study, which were radiologically and 
histologically proven liver hemangioma. The characteristics of 
14 patients with giant liver hemangiomas are shown in Table 
1. The size of liver hemangioma in our subjects ranged from 
20.1 to 28.4 cm. All cases were diagnosed as giant liver heman-
gioma with at least one lesion greater than 20 cm. There were 
12 women (85.8%) and 2 men (14.2%) with a mean age of 48.5 
(range, 29 to 68) years.
Abdominal discomfort was the main presenting feature for 
referral in 9 patients (64.2%), in which 6 patients complained 
of abdominal pain and 3 of them presented with abdominal 
distention. Two patients (14.2%) were diagnosed because of ab-
normal liver function tests. An incidental finding on abdominal 
imaging for other reasons occurred in 3 patients (21.4%).
In all the patients, the imaging findings were obtained from 
the case records. The extent and severity of the disease were 
Fig. 1. (A) Abdominal ultrasound US showing a hyperechoic mass (21.9×14.3 cm) in the right lobe with radiological characteristics of a giant 
liver hemangioma. (B) Arrow (a) shows the compressed right portal vein; (b) shows the compressed inferior vena cava with slight shifting to the 
left and anterior to the aorta (arrow c).
Fig. 2. (A) Abdominal computed tomography showing a homogenous hypodense lesion with characteristics of a hemangioma (21.9×14.3 cm) in 
the right lobe. Arrows show the characteristic nodular enhancement. (B) Arrows show three giant hemangiomas. (a) A lesion of 7.8×5.7 cm in S6; (b) 
A giant hemangioma of 20.2×7.3 cm in left lobe; (c) Another giant hemangioma of 17.7×8.5 cm in the caudate lobe.Jiang H, et al: Treatment of Hemangioma  231
evaluated by instrumental examination including hepatic US 
and abdominal spiral CT scan or magnetic resonance imaging 
(MRI). Abdominal US established the diagnosis in 12 patients 
(85.7%). Subsequent CT or MRI established the diagnosis in the 
other 2 patients. On US, liver hemangioma was usually shown 
as homogenous, hyperechoic, well-defined lesions (Fig. 1), and 
was characterized as a well-defined, homogenous, hypodense 
lesion with peripheral nodular enhancement followed by pro-
gressive centripetal enhancement on CT scan image (Fig. 2).
Transcatheter arterial embolization was implemented in 9 
patients with abdominal discomfort. Abdominal pain was alle-
viated to some extent in 6 patients with progressive abdominal 
pain. However, 3 patients got no alleviation of their abdominal 
distension. The mean size of the tumor did not show any sig-
nificant change on follow-up imaging studies.
Autologous transfusion was performed by the cell-saver ap-
paratus in all cases. Three patients had blood transfusion of 400 
to 1,200 mL, and the other 11 patients had no blood transfu-
sion. All patients had hepatic function restored after 3 to 12 
days of symptomatic treatment.
The type of liver resection had been performed on the basis of 
the size, location and typical morphology of the hemangioma 
(Table 2). Hemihepatectomy was done in 8 patients, trisectio-
nectomy was done in 4 patients, and enucleation was done in 2 
cases.
One patient with two giant hemangiomas underwent left 
hemihatectomy initially and S6 resection one year later. An-
other patient with 3 hemangiomas located in left and caudate 
lobe and S6 underwent left hemi-hepatectomy and caudate 
lobectomy (Fig. 3), and the lesion of S6 had been preserved for 
next resection to prevent hepatic failure.
All the patients had good outcomes without post operative 
Table 2. Characteristics of 14 Patients for Surgical Procedures
Patient 
no.
Transcathater 
arterial embolization 
Type of liver resection
Autologous 
transfusion,
mL
Blood 
transfusion,
mL
Postoperative 
stay, day
Postoperative 
complication
Follow-up after surgical 
procedures
1 Right hemihepatec-
tomy
850 0 7 No No abdominal discomfort
2 Right hepatic artery Hemangioma enucle-
ation
1,200 600 11 No No abdominal discomfort
3 Left hemihepatectomy 500 0 6 No No abdominal discomfort
4 Left hepatic artery Left trisectionectomy 1,100 400 12 Abdominal serous 
collection in the 
raw surface of 
liver remnant
No abdominal discomfort
5 Right hepatic artery Right trisectionec-
tomy
1,000 0 11 No No abdominal discomfort
6 Hemangioma enucle-
ation
1,400 0 8 No No abdominal discomfort
7 Right hepatic artery Right trisectionec-
tomy
850 0 7 No No abdominal discomfort
8 Right hemihepatec-
tomy
500 0 6 No No abdominal discomfort
9 Left hemihepatectomy 
and S6 resection in 
the second surgical 
procedure
1,200 0 9 No Persistent elevated pa-
rameters of ALT and AST
10 Right hepatic artery Right trisectionec-
tomy
900 0 13 Lung infection No abdominal discomfort
11 Right hepatic artery Right hemihepatec-
tomy
650 0 6 No No abdominal discomfort
12 Left hepatic artery Left hemihepatectomy 
and caudate resec-
tion
1,600 1,200 14 Abdominal serous 
collection in the 
raw surface of 
liver remnant
No abdominal discomfort
13 Right hepatic artery Right hemihepatec-
tomy
1,250 0 7 No No abdominal discomfort
14 Left hepatic artery Left hemihepatectomy 950 0 8 No No abdominal discomfort232  Gut and Liver, Vol. 5, No. 2, June 2011
complications except abdominal serous collection in the raw 
surface of liver remnant in 2 cases and lung infection in 1 case. 
During the follow-up of surgical procedures, all the patients had 
no abdominal discomfort with normal liver function, except one 
case who had hepatitis B infection with markedly elevated ALT 
and AST level.
DISCUSSION
Liver hemangioma occurs more frequently in women than 
in men, and is believed to be related to levels of female hor-
mones.
4 Majority of the patients in present study has solitary 
lesion and multiple lesions found in only 14.2% of the patients, 
comparable to other reports.
5,6 The main reason for referral was 
abdominal discomfort in our series (64.2%), and abdominal US 
established the diagnosis in most cases. Helical CT or MRI was 
also important in precise location of the hemangioma diagnosis 
and selection of operation methods.
Most liver hemangiomas remain stable in size. It has been 
proposed that asymptomatic patients with hemangiomas less 
than 5 cm require no intervention therapy. Also, the patients 
with giant hemangiomas with no symptoms can be observed 
safely without the chance of developing complications.
7 Sch-
nelldorfer et al.
8 reported that clinical observation is prefered in 
most patients with giant hemangioma in a recent retrospective 
cohort study. The occurrence of spontaneous rupture is rare, 
even in giant hemangiomas.
9 However, in our experience, most 
patients with hemangioma greater than 20 cm have abdominal 
discomfort, among which some patients have progressive ab-
dominal pain or distension. For those patients, selective trans-
catheter arterial embolization was performed for alleviating 
symptom during the period of waiting for surgical procedure. As 
a result in our center, abdominal pains were alleviated to some 
extent in 6 (6/9) patients and no rupture occurred. However, the 
mean size of the tumor did not show any significant change on 
follow-up imaging studies, and no alleviation for distention in 
all 3 patients.
Different treatment modalities of liver hemangiomas apart 
from resection have been described, such as ligation of hepatic 
artery
10 or liver transplantation for giant unresectable lesions.
11 
Selective transcatheter arterial embolization
12 and radiation 
therapy
13 have also been reported. However, these methods 
are unsuccessful in the long term except for liver transplanta-
tion. Not all the patients with giant hemangioma are fit for 
liver transplantation for their good hepatic function. The lack 
of donors, high expenses for transplantation and postoperative 
immune rejections are all the hazards which we took concern 
about. Therefore, the treatment choice remains liver resection.
Some reports have mentioned that enucleation is a better 
option than resection for giant hemangioma with less intra-
operative blood loss and less postoperative hospital stay.
14,15 
However, the mean size of lesions reported was almost not 
greater than 10 cm, and the majority of subjects taken into ac-
count were solitary hemangioma. Hamaloglu et al.
16 reported 
enucleation should be considered in the case of anterior and su-
perficial hemangiomas. In our experience, enucleation for giant 
lesions greater than 20 cm is difficult and would result in more 
intro-operative blood loss due to attachment of many vascular 
structures adjacent to it. However, for liver resection, the infra- 
and suprahepatic IVC were liberated and then taped to control 
blood flow, and the same was done for hepatic pedicle. The 
hepatic artery and portal vein of lesion side were ligated and 
cut down, and the diminution in size of the hemangioma when 
squeezed was visualized, which could decrease the bleeding at 
the incisional edge.
For multiple giant liver hemangiomas, it is difficult to deal 
with all the lesions at one time for the reason of preservation 
of enough liver parenchyma, which is critical for the success of 
the operation. In our center, we tried to resect all the lesions at 
one time. However, considering the small liver remnant, long 
Fig. 3. (A) Giant liver hemangiomas on the operating table. (B) The remnant of the liver before abdominal wall closure. The arrow shows the le-
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operating time, large intraoperative bleeding and poor coagula-
tion for massive blood transfusion, we strongly recommended 
staged resection for multiple giant liver hemangiomas. For 
example, one patient with two giant hemangiomas underwent 
left hemihetactomy initially and S6 resection one year later. She 
had recovered successfully and had a good follow-up. Another 
patient with abdominal pain had three giant hemangiomas, 
for which we recommended liver transplantation. However, 
she strongly asked for resection because of donor shortage and 
high expenses for transplantation. Considering her undamaged 
hepatic function, we implemented left hemihepatectomy and 
caudate resection at first (Fig. 3). The patient recovered 14 days 
after operation and would undergo S6 resection one year later. 
She was asked for follow up every 3 months consecutively, by 
which her hepatic function and liver imaging can be assessed.
Patient with multiple giant hemangioma who underwent first 
operation, was needed strict follow-up to assess liver function 
and regeneration. If the lesion did not affect the major vessels 
or not get bigger in size or not cause any clinical manifestation, 
we did not go for second resection, but we asked them regular 
follow-up for clinical observation.
In conclusion, liver resection is indicated for giant liver hem-
angiomas with abdominal discomfort, especially for lesions 
greater than 20 cm, and staged operation is adopted for the pa-
tients with multiple lesions. Preoperative selective transcatheter 
arterial embolization is good to alleviate progessive abdominal 
pain, but no use to change the size of lesions.
Our study can be criticized for its patient and treatment se-
lection, the lack of report of nonoperative management when 
introducing surgical management, as well as the retrospective 
nature of assessment of outcome. However, it highlights the 
possibility of surgical management for hemangiomas greater 
than 20 cm.
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